The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study

Further Publications Rheumatology

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicenter study of 471 cases

Rheumatology (Oxford)

Blanco R, Aldasoro V, Maiz O, Melero R, Romero-Yuste S, de Miguel E, Ferraz-Amaro I, López-Gutiérrez F, Castañeda S, Loricera J, Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group

doi: 10.1093/rheumatology/keae666

Further Publications Rheumatology

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Arthritis Res Ther

Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, de Miguel E, Silva-Díaz M, Valero Jaimes JA, González I, Sánchez Martín J, Narváez J, Calvet J, Casafont-Solé I, Román Ivorra JA, Labrada Arrabal S, Vasques Rocha M, Iñiguez CL, Bustabad Reyes MS, Campos Fernández C, Alcalde Villar M, Mas AJ, Blanco R, ARTESER Project Collaborative Group

doi: 10.1186/s13075-024-03468-6

Further Publications Immunology

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

J Eur Acad Dermatol Venereol

Bejarano L, Grau-Pérez M, Paíno-Román M, Muret MPG, Morillo M, Muniesa C, Torre-Castro J, Estrach MT, Díez EA, Belloso RML, Peñate Y, Martínez-Mera C, Botella-Estrada R, Eceiza MJM, Ortiz Romero PL, Blanes M, Fernández-de-Misa R, Prieto-Torres L, Amer MEP, Iznardo H, Moreno-Vílchez C, Servitje O, García-Doval I, Cañueto J

doi: 10.1111/jdv.20638

Further Publications Rheumatology

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)

Ann Rheum Dis

Pers YM, Soler-Rich R, Vadalà G, Ferreira R, Duflos C, Picot MC, Herman F, Broussous S, Sánchez A, Noriega D, Ardura F, Alberca Zaballos M, García V, Gordillo Cano V, González-Vallinas M, Denaro V, Russo F, Guicheux J, Vilanova J, Orozco L, Meisel HJ, Alfonso M, Rannou F, Maugars Y, Berenbaum F, Barry FP, Tarte K, Louis-Plence P, Ferreira-Dos-Santos G, García-Sancho J, Jorgensen C, RESPINE consortium

doi: 10.1136/ard-2024-225771

Rheumatoid Arthritis

Association of patient- and hospital-level predictors with patterns of initial treatment in patients with Rheumatoid Arthritis: findings from a national cohort study

Rheumatology (Oxford)

Yang Z, Alveyn E, Russell M, Bechman K, Coalwood C, Price E, Abhishek A, Norton S, Galloway J

doi: 10.1093/rheumatology/keae717

Further Publications Rheumatology

Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

Rheumatology (Oxford)

Martín-Gutiérrez A, Molina-Collada J, Domínguez-Álvaro M, Melero-González RB, Fernández-Fernández E, Silva-Díaz M, Valero JA, González I, Martín JS, Narváez J, Calvo I, Aldasoro V, Abasolo Alcázar L, Loricera J, Ruíz-Roman A, Castañeda S, Molina-Almela C, Alcalde Villar M, Juan Mas A, Blanco R, ARTESER Project Collaborative Group

doi: 10.1093/rheumatology/keaf051

Psoriasis

Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicenter study

Rheumatology (Oxford)

Azuaga AB, Cuervo A, Reina D, Alarcón PE, Mateo L, Aparicio M, Moreno M, Arévalo M, Láiz A, Moya P, Alascio L, Riera J, Scher JU, Cañete JD, Ramírez J

doi: 10.1093/rheumatology/keaf307

Further Publications Rheumatology

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

N Engl J Med

Blockmans D, Penn SK, Setty AR, Schmidt WA, Rubbert-Roth A, Hauge EM, Keen HI, Ishii T, Khalidi N, Dejaco C, Cid MC, Hellmich B, Liu M, Zhao W, Lagunes I, Romero AB, Wung PK, Merkel PA, SELECT-GCA Study Group

doi: 10.1056/NEJMoa2413449

Allergic Diseases

Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

Contact Dermatitis

Pesqué D, Planella-Fontanillas N, Borrego L, Sanz-Sánchez T, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel FJ, Silvestre-Salvador JF, Córdoba-Guijarro S, Sánchez-Gilo A, Mercader-García P, Navarro-Triviño FJ, Ortiz-de-Frutos FJ, Tous-Romero F, Rodríguez-Serna M, Melé-Ninot G, Barrabés-Torrella C, Ruiz-González I, Pastor-Nieto MA, Carrascosa-Carrillo JM, Gómez-de-la-Fuente E, Sánchez-Pedreño-Guillén P, Sánchez-Pérez J, Pereyra-Rodríguez JJ, Gatica-Ortega ME, González-Pérez R, Pujol RM, Descalzo MÁG, García-Doval I, Giménez-Arnau AM

doi: 10.1111/cod.14702

Related content

Tocilizumab in cranial and extracranial giant cell arteritis: a national multicenter study of 471 cases

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)

Association of patient- and hospital-level predictors with patterns of initial treatment in patients with Rheumatoid Arthritis: findings from a national cohort study

Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

Clinical and ultrasound features of a cohort of psoriasis patients without musculoskeletal symptoms: a prospective and multicenter study

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023